Hepion Pharmaceuticals, Inc. HEPA Stock
Hepion Pharmaceuticals, Inc. Price Chart
Hepion Pharmaceuticals, Inc. HEPA Financial and Trading Overview
| Hepion Pharmaceuticals, Inc. stock price | 2.19 USD |
| Previous Close | 11.49 USD |
| Open | 11.21 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 11.2 - 11.9 USD |
| 52 Week Range | 5.2 - 23.86 USD |
| Volume | 59.84K USD |
| Avg. Volume | 352.68K USD |
| Market Cap | 44.1M USD |
| Beta (5Y Monthly) | 1.647535 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -12.42 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 44 USD |
HEPA Valuation Measures
| Enterprise Value | 2.8M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.2153361 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2436848 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.057 |
Trading Information
Hepion Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 1.647535 |
| 52-Week Change | -17.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 23.86 USD |
| 52 Week Low | 5.2 USD |
| 50-Day Moving Average | 12.39 USD |
| 200-Day Moving Average | 11.82 USD |
HEPA Share Statistics
| Avg. Volume (3 month) | 352.68K USD |
| Avg. Daily Volume (10-Days) | 94.15K USD |
| Shares Outstanding | 3.81M |
| Float | 3.81M |
| Short Ratio | 0.25 |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | 238.24K |
| Short % of Float | 6.26% |
| Short % of Shares Outstanding | 6.25% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.63% |
| Return on Equity (ttm) | -78.40% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -49501732 USD |
| Net Income Avi to Common (ttm) | -51667784 USD |
| Diluted EPS (ttm) | -14.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 42.99M USD |
| Total Cash Per Share (mrq) | 11.28 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.674 |
| Book Value Per Share (mrq) | 9.303 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33046374 USD |
| Levered Free Cash Flow (ttm) | -16466123 USD |
Profile of Hepion Pharmaceuticals, Inc.
| Country | United States |
| State | NJ |
| City | Edison |
| Address | 399 Thornall Street |
| ZIP | 08837 |
| Phone | 732-902-4000 |
| Website | https://www.hepionpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 25 |
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in phase 2 clinical development for the treatment of non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.
Q&A For Hepion Pharmaceuticals, Inc. Stock
What is a current HEPA stock price?
Hepion Pharmaceuticals, Inc. HEPA stock price today per share is 2.19 USD.
How to purchase Hepion Pharmaceuticals, Inc. stock?
You can buy HEPA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hepion Pharmaceuticals, Inc.?
The stock symbol or ticker of Hepion Pharmaceuticals, Inc. is HEPA.
Which industry does the Hepion Pharmaceuticals, Inc. company belong to?
The Hepion Pharmaceuticals, Inc. industry is Biotechnology.
How many shares does Hepion Pharmaceuticals, Inc. have in circulation?
The max supply of Hepion Pharmaceuticals, Inc. shares is 4.34M.
What is Hepion Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Hepion Pharmaceuticals, Inc. PE Ratio is now.
What was Hepion Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Hepion Pharmaceuticals, Inc. EPS is -12.42 USD over the trailing 12 months.
Which sector does the Hepion Pharmaceuticals, Inc. company belong to?
The Hepion Pharmaceuticals, Inc. sector is Healthcare.
Hepion Pharmaceuticals, Inc. HEPA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}